Navigation Links
Rutgers-affiliated company receives funding for technology to help choose breast cancer treatments
Date:10/6/2011

NEW BRUNSWICK, N.J. The National Institutes of Health (NIH) has awarded a Rutgers-affiliated company $207,000 to develop a quick and economical analysis of tissue from breast cancer biopsies. The technology is designed to predict how aggressive a common form of breast cancer is likely to be, helping physicians and patients plan effective therapies that minimize side effects.

The NIH made its grant to Ibris, Inc., through the Small Business Innovation Research program, which federal funding agencies use to encourage American businesses to engage in research and development with commercial potential. Ibris, Inc. is a Piscataway, N.J.-based start-up company that is negotiating a license for computerized image recognition technology developed by Anant Madabhushi, professor of biomedical engineering in the Rutgers School of Engineering.

"Each year, about 120 thousand women in the U.S. and a million women worldwide are diagnosed with ER positive breast cancer," said Madabhushi. Those with less aggressive forms of the disease may respond solely to hormonal therapy, typically tamoxifen, but those with more aggressive forms will also require chemotherapy.

"By determining how aggressive the tumor is, we can help those with less aggressive cancer avoid chemotherapy with its side-effects and expense, and at the same time, we can help those with more aggressive cancer get immediate access to the treatment they need to fight the disease."

Madabhushi's technology examines a high-resolution digital image of biopsy specimens, using computerized image analysis tools to reveal difficult-to-discern characteristics that indicate the disease's grades of severity. It builds on earlier research to detect and grade prostate cancer by analyzing magnetic resonance images of the gland.

The current diagnostic procedure is for a pathologist to examine samples of suspicious tissue to determine whether it is cancerous, and if so, classify the
'/>"/>

Contact: Carl Blesch
cblesch@ur.rutgers.edu
732-932-7084 x616
Rutgers University
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
2. Lockheed Martin Named Biometrics Company of the Year by Frost and Sullivan
3. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
4. Explorations Group Announces Letter of Intent to Acquire Specialty Lighting Company
5. Lockheed Martin Named Biometrics Company of the Year by Frost and Sullivan
6. Iowa State chemist synthesizes carbohydrates, launches startup company
7. ExcellGene SA first company to offer contract manufacturing in 250 Liter OrbShake bioreactor
8. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
9. Two is not company -- as far as fish are concerned
10. GATC Biotech AG is investing more than 5 million euros in its Constance site to double the companys floor space
11. Company Granted Patent on Apparatus, Systems, and Methods for Gathering and Processing Wireless Biometric and Biomechanical Data
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rutgers-affiliated company receives funding for technology to help choose breast cancer treatments
(Date:4/14/2015)... YORK , April 14, 2015  HYPR ... IDentity Online (FIDO ® ) Alliance tm , ... specifications. FIDO members commit to share technology and ... methods that are interoperable, more secure and private, ... enable biometric identity verification that protects sensitive user ...
(Date:4/13/2015)... , April 13, 2015  higi, a leading ... ways to more fully engage with their communities around ... industry-leading, privacy protected and secure API.  ... enables the most accessible, affordable, and convenient vehicle to ... The API will allow ...
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... new study by researchers at the University of California, ... that promoting cleaner, more efficient technologies for producing charcoal ... significant climate change and development benefits. , The African ... and Latin America, is dependent on both wood and ...
... Linus Pauling's book Vitamin C and The Common Cold, published ... believe in the value of the vitamin for cold prevention ... reviewing all of the best clinical research on this topic, ... unjustified. , Robert M Douglas of the Australian National University, ...
... critical piece of synapse-associated protein 97 (SAP97) found in abundance ... play a role in everything from cardiac contractions to memory ... , Dale Mierke, associate professor of medical science at Brown, ... is an important step. Now that part of the protein's ...
Cached Biology News:Study of energy and health in Africa focuses spotlight on charcoal and forest management 2Study of energy and health in Africa focuses spotlight on charcoal and forest management 3Does vitamin C help prevent or treat the common cold? Maybe not, after all. 2Researchers reveal secret of key protein in brain and heart function 2
(Date:4/16/2015)...  In recognition of World Hemophilia Day, Biogen  (NASDAQ: ... illuminate more than 15 prominent landmarks red throughout ... Zakim Bridge and Prudential Tower, Chicago,s ... Superdome and Denver,s Coors Field ... 17, and coincide with hemophilia community events in a dozen ...
(Date:4/16/2015)... April 16, 2015 ... pharmaceutical investment and R&D group, and Lancet, ... research, development and commercialization of new medicines ... the intention to stimulate the innovative development ...      (Logo: http://photos.prnewswire.com/prnh/20150416/739742-a) ,     (Logo: http://photos.prnewswire.com/prnh/20150416/739742-b) , ...
(Date:4/16/2015)... , April 16, 2015 Avelas Biosciences, ... to improving cancer surgeries, announced today that it has ... cancer illuminator, AVB-620, in women with primary, non-recurrent breast ... company also welcomed the addition of Steven Chen ... The open label, dose escalation study will enroll ...
(Date:4/16/2015)... (PRWEB) April 16, 2015 Fairleigh ... Joseph V. Gulfo to become the Executive Director ... Simultaneously, FDU announced the kick-off of the Initiative ... spearheaded by Dr. Gulfo, under the Rothman Institute ... of Business) and in collaboration with FDU’s School ...
Breaking Biology Technology:Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 2Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 3Biogen Shines A Light On Hemophilia Community By Illuminating U.S. Landmarks Red On World Hemophlia Day 4Lancet and ChemRar High Tech Center Have Announced a Partnership in the Development and Production of Novel Drugs in Russia 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3
... 18 Premier Research Group plc (AIM:,PRG) announces ... Vice President,Global Human Resources. Mr. Keenen will be ... related to maximizing the,effectiveness of Premier Research,s people ... Dr. Troy McCall, COO, commented: "We are ...
... Ultra-low power DSP core from CEVA provides unmatched ... for state-of-the-art cochlear implant system, SAN JOSE, ... ; LSE: CVA), a leading licensor of innovative ... wireless, consumer and,multimedia applications, today announced that Advanced ...
... TOKYO, September 18 Sosei Group Corporation,("Sosei"; TSE ... AD 337, an enantiomer of an approved, centrally ... of principle trial,for the treatment of fibromyalgia syndrome ... placebo,controlled, parallel group exploratory study, investigated the efficacy,safety ...
Cached Biology Technology:Premier Research Appoints Global Head of Human Resources 2Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System 2Advanced Bionics Deploys CEVA-TeakLite(TM) DSP Core to Enhance Its Harmony(TM) HiResolution(R) Bionic Ear System 3Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome 2
... & visualization software. See ... samples. Combine Sequest and ... confidence. Get more detailed ... your MS/MS experiments.14 day ...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
...
...
Biology Products: